
Fralin Biomedical Research Institute biotech spin-out raises $305K
A cancer stem cell research company founded by Fralin Biomedical Research Institute at VTC scientists is nearing a million dollars in total funding toward development of a new therapeutic to fight drug-resistant cancers.








